STUDY OF CLINICAL PROFILE OF THE PATIENTS WITH DEEP VEIN THROMBOSIS AND ITS RESPONSE TO LOW MOLECULAR WEIGHT HEPARIN

Dr. Amitabh Kumar, Dr. Amitabh Kumar, Dr. Amitabh Kumar, Dr. Madan Pal Singh
Page No: 83-90
DOI: 10.86493/OTJ.2433309
Download PDFAbstract:
Deep vein thrombosis of the lower extremity is a leading cause of inhospital mortality. Complications of deep vein thrombosis include pulmonary embolism, recurrent episodes of deep vein thrombosis, and the development of postthrombotic syndrome. Low-molecular-weight heparins have longer half life, more predictable anticoagulant response and are suitable for subcutaneous administration without laboratory monitoring.

Citations

APA: Dr. Amitabh Kumar, Dr. Amitabh Kumar, Dr. Amitabh Kumar, Dr. Madan Pal Singh (2025). STUDY OF CLINICAL PROFILE OF THE PATIENTS WITH DEEP VEIN THROMBOSIS AND ITS RESPONSE TO LOW MOLECULAR WEIGHT HEPARIN. DOI: 10.86493/OTJ.2433309

AMA: Dr. Amitabh Kumar, Dr. Amitabh Kumar, Dr. Amitabh Kumar, Dr. Madan Pal Singh. STUDY OF CLINICAL PROFILE OF THE PATIENTS WITH DEEP VEIN THROMBOSIS AND ITS RESPONSE TO LOW MOLECULAR WEIGHT HEPARIN. 2025. DOI: 10.86493/OTJ.2433309

Chicago: Dr. Amitabh Kumar, Dr. Amitabh Kumar, Dr. Amitabh Kumar, Dr. Madan Pal Singh. "STUDY OF CLINICAL PROFILE OF THE PATIENTS WITH DEEP VEIN THROMBOSIS AND ITS RESPONSE TO LOW MOLECULAR WEIGHT HEPARIN." Published 2025. DOI: 10.86493/OTJ.2433309

IEEE: Dr. Amitabh Kumar, Dr. Amitabh Kumar, Dr. Amitabh Kumar, Dr. Madan Pal Singh, "STUDY OF CLINICAL PROFILE OF THE PATIENTS WITH DEEP VEIN THROMBOSIS AND ITS RESPONSE TO LOW MOLECULAR WEIGHT HEPARIN," 2025, DOI: 10.86493/OTJ.2433309

ISNAD: Dr. Amitabh Kumar, Dr. Amitabh Kumar, Dr. Amitabh Kumar, Dr. Madan Pal Singh. "STUDY OF CLINICAL PROFILE OF THE PATIENTS WITH DEEP VEIN THROMBOSIS AND ITS RESPONSE TO LOW MOLECULAR WEIGHT HEPARIN." DOI: 10.86493/OTJ.2433309

MLA: Dr. Amitabh Kumar, Dr. Amitabh Kumar, Dr. Amitabh Kumar, Dr. Madan Pal Singh. "STUDY OF CLINICAL PROFILE OF THE PATIENTS WITH DEEP VEIN THROMBOSIS AND ITS RESPONSE TO LOW MOLECULAR WEIGHT HEPARIN." 2025, DOI: 10.86493/OTJ.2433309